论文部分内容阅读
我们在 １９９８年 ７月－ ２０００年 １２月静脉应用三氧化二砷（Ａｓ２Ｏ３）注射液单药治疗原发性肝癌，取得一定疗效，现报告如下。 一、资料与方法 １．一般资料：本组共２８例，男２６例，女２例，年龄２８～７１岁（中位年龄４８岁）；１２例经病理组织学和／或细胞学
We in July 1998 - December 2000 intravenous arsenic trioxide (As2O3) injection of single-agent treatment of primary liver cancer, and achieved a certain effect, are as follows. First, data and methods 1. General Information: The group of 28 patients, 26 males and 2 females, aged 28 to 71 years (median age 48 years); 12 cases of histological and / or cytology